The UK charity for Waldenstrom’s macroglobulinaemia – a rare type of blood cancer
Support Line: 0300 373 8500

Showing only trials that are North East England

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
Testing a new treatment to understand it’s efficacy and the best dose for patients
Expected to end: 31/03/2028
A study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma
An early phase study of the efficacy and safety of a new drug
Expected to end: 08/01/2026
Oxford Pre-cancerous Lymphoproliferative Disorders Study (OxPLoreD)
Looking for markers that might predict disease is progressing
Expected to end: 01/10/2025